North Wales, PA, United States of America

Wei-Qin Zhao

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 6.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Bethesda, MD (US) (2015)
  • North Wales, PA (US) (2011 - 2016)
  • West Point, PA (US) (2016)

Company Filing History:


Years Active: 2011-2016

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Wei-Qin Zhao

Introduction

Wei-Qin Zhao is a notable inventor based in North Wales, PA, with a significant contribution to the field of biomedical research. He holds a total of five patents, showcasing his innovative approaches to addressing critical health issues, particularly in the realm of Alzheimer's disease.

Latest Patents

One of his latest patents is a method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42. This invention includes a method and kit that utilizes an antibody or antibody fragment with a higher affinity for amyloid beta 1-42 oligomers than for other forms of amyloid beta. This innovative approach aims to treat diseases resulting from the accumulation of these oligomers. Another significant patent is the development of an anti-ADDL monoclonal antibody and its uses. This invention focuses on antibodies that bind to amyloid β-derived diffusible ligands, known as ADDLs. These antibodies are designed to penetrate the brain and are useful in detecting ADDLs and diagnosing Alzheimer's disease. They also play a role in blocking the binding of ADDLs to neurons, which is crucial for preventing and treating diseases associated with these ligands.

Career Highlights

Wei-Qin Zhao has worked with prominent companies in the pharmaceutical industry, including Acumen Pharmaceuticals, Inc. and Merck Sharp & Dohme Corporation. His experience in these organizations has contributed to his expertise in developing innovative solutions for complex medical challenges.

Collaborations

Throughout his career, Wei-Qin Zhao has collaborated with esteemed colleagues, including Renee C. Gaspar and Paul J. Shughrue. These collaborations have likely enhanced his research and development efforts, leading to impactful innovations in the field.

Conclusion

Wei-Qin Zhao's contributions to the field of biomedical research, particularly in the treatment of Alzheimer's disease, highlight his role as a significant inventor. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…